Imperial College Of Science; Technology And Medicine
发明人:
申请号：
EP18795716.2
公开号：
EP3694866A1
申请日:
2018.10.12
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There are also provided processes for producing compounds of the present invention and method of their use. In particular, the present invention relates to compounds of formula (I).
